The problem — Until recently, microscopy data accompanying a publication either lived on a lab server (ephemeral, inaccessible) or was deposited in a specialist archive designed for one modality — EMPIAR for electron microscopy, IDR for high-content screening — leaving light-sheet, live-cell, spatial omics, and the long tail of one-off experiments with no generalist home. Without a cross-modality public archive, reproducibility is constrained to the subset of labs that can obtain the original files, and FAIR data principles remain aspirational rather than operational.
What it is / how it works — The BioImage Archive, operated by EMBL-EBI in collaboration with Euro-BioImaging and ELIXIR, is an open-access repository that accepts biological image submissions from any imaging modality, provided data are associated with a peer-reviewed publication or have broader research value. It implements REMBI as its metadata standard, so each deposited study carries the acquisition and sample-context fields needed to make datasets searchable and computationally reusable. As of 2024 the archive holds more than 2,500 datasets. Deposition is free; data are publicly downloadable. The archive also provides archiving services to existing domain resources — EMPIAR, Cell-IDR, Tissue-IDR — positioning it as the connective layer across the bioimaging data ecosystem. For Fovea pipelines, the BioImage Archive is both a reference corpus (validated, REMBI-annotated datasets for benchmarking and training) and a deposition target for client studies that require public data release alongside publication. This is where run manifest discipline pays off: a pipeline that captures REMBI fields at ingest can generate a deposition package as a byproduct, not an afterthought.
Where it breaks — The archive stores what is deposited; it does not audit it. A REMBI record with a filled study title and an empty acquisition module passes submission but fails reuse — the downstream researcher cannot validate pixel-size assumptions or reproduce the illumination conditions. The practical discipline for any pipeline targeting public deposition is to validate REMBI completeness at ingest, not at submission time.